The Association Between the Rational Use of Antihypertensive Drugs and Blood Pressure Control in Non-Hemorrhagic Stroke Patients Hospitalized at X Hospital Surakarta in 2024
Article Sidebar
Main Article Content
Page: 2963-2975
Abstract
Background: Non-hemorrhagic stroke or ischemic stroke is the most common type of stroke and remains one of the leading causes of mortality and long-term disability. Blood pressure management through antihypertensive therapy is a key component of secondary prevention; however, variations in clinical practice indicate that the rational use of these medications still requires evaluation. Objective: This study aims to determine the relationship between the rationality of antihypertensive therapy and blood pressure control in non-hemorrhagic stroke patients based on clinical parameters in the inpatient ward of Hospital X, Surakarta. Methods: This research employed an analytical observational design with a retrospective cross-sectional approach. Data on antihypertensive use were collected from medical records of patients hospitalized in 2024, and a total of 100 patients met the inclusion criteria. Data analysis was performed using the Chi-square test. Results: Among non-hemorrhagic stroke patients in the inpatient ward of Hospital X Surakarta in 2024, 90 patients received rational antihypertensive therapy. Antihypertensive treatment was predominantly from the dihydropyridine CCB class, particularly amlodipine, either as monotherapy or in combination. Fisher’s exact test analysis showed a p-value < 0.05, indicating a significant association between the rationality of antihypertensive therapy and blood pressure control. Conclusion: There is a significant relationship between the rationality of antihypertensive therapy and blood pressure control in non-hemorrhagic stroke patients, highlighting the importance of rational drug selection as a crucial aspect of secondary prevention strategies.
Downloads
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
References
Setiawan P ayunda. Diagnosis Dan Tatalaksana Stroke Hemoragik. Jurnal Medika Utama 2021;03:1660–5.
Puspitasari PN. Hubungan Hipertensi Terhadap Kejadian Stroke. Jurnal Ilmiah Kesehatan Sandi Husada 2020;12:922–6. https://doi.org/10.35816/jiskh.v12i2.435. DOI: https://doi.org/10.35816/jiskh.v12i2.435
Liu J, Xu A, Zhao Z, Ren B, Gao Z, Fang D, et al. Epidemiology and future trend predictions of ischemic stroke based on the global burden of disease study 1990–2021. Communications Medicine 2025;5:1–15. https://doi.org/10.1038/s43856-025-00939-y. DOI: https://doi.org/10.1038/s43856-025-00939-y
Harris S, Kurniawan M, Rasyid A, Mesiano T, Hidayat R. Cerebral small vessel disease in Indonesia: Lacunar infarction study from Indonesian Stroke Registry 2012–2014. SAGE Open Med 2018;6:1–6. https://doi.org/10.1177/2050312118784312. DOI: https://doi.org/10.1177/2050312118784312
Apriyani S, Herawati T. Pengembangan Dan Penerapan Rekam Medis Elektronik (Rme) Dalam Memantau Insiden Hipertensi: Telaah Jurnal. Jurnal Mitra Kesehatan 2020;3:11–5. https://doi.org/10.47522/jmk.v3i1.45. DOI: https://doi.org/10.47522/jmk.v3i1.45
Rahmatika AF. Hubungan Merokok Dengan Kejadian Hipertensi. Jurnal Medika Hutama 2021;2:706–10.
Diontama MA, Lastari T, Jausal AN. Article Review : Peran Hipertensi terhadap Patomekanisme Stroke Iskemik dan Hemoragik. Termometer: Jurnal Ilmiah Ilmu Kesehatan Dan Kedokteran 2025;3:183–91. https://doi.org/https://doi.org/10.55606/termometer.v3i1.4752. DOI: https://doi.org/10.55606/termometer.v3i1.4752
Suciati E, Luthfiyanti N, Listyani TA. Hubungan Kerasionalan Peresepan Obat Antihipertensi Dengan Outcome Klinis Terhadapi Pasien Stroke Iskemik Rawat Inap Di RSUD DR. Moewardi Surakarta. Jurnal Kesehatan Tambusai 2024;5:9196–206. DOI: https://doi.org/10.31004/jkt.v5i4.38627
Nababan OA, Marbun M, Sipayung, Hekdin Marsius, Simbolon YPS. Perbandingan Efikasi Kombinasi Ace-I + Ccb Dan Ace-I + Diuretik Terhadap Penurunan Tekanan Darah Pada Pasien Stroke Iskemik Di Rawat Jalan Rumah Sakit Efarina Etaham Pematangsiantar. Jurnal Ilmu Kesehatan 2024;9:1–6. https://doi.org/10.5455/mnj.v1i2.644xa.
Muhlis M, Iffa Muslimah L. Hubungan Kerasionalan Peresepan Obat Antihipertensi Dengan Outcome Klinis Pada Pasien Stroke Iskemik Rawat Inap RSUD Dr. Soegiri Lamongan. Jurnal Farmasi Indonesia 2021;18:47–59. DOI: https://doi.org/10.23917/pharmacon.v18i01.13230
Kleindorfer DO, Towfighi A, Chaturvedi S, Cockroft KM, Gutierrez J, Lombardi-Hill D, et al. 2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack. vol. 52. 2021. https://doi.org/10.1161/STR.0000000000000375. DOI: https://doi.org/10.1161/STR.0000000000000375
Juwita DA, Almasdy D, Hardini T. Evaluasi Penggunaan Obat Antihipertensi pada Pasien Strok Iskemik di Rumah Sakit Strok Nasional Bukittinggi. Jurnal Farmasi Klinik Indonesia 2018;7:99–107. https://doi.org/10.15416/ijcp.2018.7.2.99. DOI: https://doi.org/10.15416/ijcp.2018.7.2.99
Appelros P, Stegmayr B, Terent A. Sex Differences in Stroke Epidemiology: A systematic review. Stroke 2009;40:1082–90. https://doi.org/10.1161/STROKEAHA.108.540781. DOI: https://doi.org/10.1161/STROKEAHA.108.540781
Fitriany NN, Affandi IG. Penelitian Hubungan Usia Dan Jenis Kelamin Dengan Kejadian Stroke Di RSUD KHZ Musthafa Tasikmalaya Tahun 2023. Neurona 2025;41. https://doi.org/https://doi.org/10.52386/neurona.v41i2.646. DOI: https://doi.org/10.52386/neurona.v41i2.646
Ghani L, Mihardja LK, Delima. Faktor Risiko Dominan Penderita Stroke di Indonesia. Buletin Penelitian Kesehatan 2016;44:49–58. DOI: https://doi.org/10.22435/bpk.v44i1.4949.49-58
Bakrie ZA, Arifin AF, Muchsin AH, Kartika ID, Irmayanti. Hubungan Kadar Leukosit Pada Pasien Stroke Iskemik. Jurnal Mahasiswa Kedokteran 2022;4:359–67. https://doi.org/https://doi.org/10.33096/fmj.v4i6.391. DOI: https://doi.org/10.33096/fmj.v4i6.391
Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, et al. 2018 ESC/ESHGuidelines for the management of arterial hypertension. Eur Heart J 2018;39:3021–104. https://doi.org/10.1097/HJH.0b013e3281fc975a. DOI: https://doi.org/10.1097/HJH.0b013e3281fc975a
Tuloli TS, Reski Manno M, Tungadi R, Nurrohwinta Djuwarno E. Antihypertensive Therapy Patterns in Prolanis Patients at North Gorontalo City Health Centre, Indonesia. Journal Syifa Sciences and Clinical Research 2025;7:284–92. https://doi.org/10.37311/jsscr.v7i3.34245. DOI: https://doi.org/10.37311/jsscr.v7i3.34245
Elavia LI, Zullies I, Andayani TM. Perbandingan Efektivitas Antihipertensi pada Terapi Stroke Iskemik: Kajian Literatur. Majalah Farmaseutik 2024;20:373–81. https://doi.org/10.22146/farmaseutik.v20i3.97086. DOI: https://doi.org/10.22146/farmaseutik.v20i3.97086
Chen GJ, Yang MS. The Effects of Calcium Channel Blockers in the Prevention of Stroke in Adults with Hypertension : A Meta-Analysis of Data from 273 , 543 Participants in 31 Randomized Controlled Trials. PLOS 2013;8. https://doi.org/10.1371/journal.pone.0057854. DOI: https://doi.org/10.1371/journal.pone.0057854
Chen I-W, Lin Y-H, Wu V-C, Chen J-Y, Wu M-H. Discontinuation versus continuation of renin–angiotensin system inhibitors in chronic kidney disease stage 3–5 patients: a systematic review and meta-analysis. Frontiers (Boulder) 2025;16:1–10. https://doi.org/10.3389/fphar.2025.1646969. DOI: https://doi.org/10.3389/fphar.2025.1646969
Safira AG, Farmasi PS, Semarang UD. Evaluasi Rasionalita Penggunaan Obat Golongan Penyekat Beta Pada Pasien Gagal Jantung Di Rumah Sakit Daerah K.R.M.T. Journal of Research in Pharmacy 2025;5:123–30. https://doi.org/https://doi.org/10.14710/genres.v5i2.25626. DOI: https://doi.org/10.14710/genres.v5i2.25626
DiNicolantonio JJ, Fares H, Niazi AK, Chatterjee S, D’Ascenzo F, Cerrato E, et al. β-Blockers in hypertension, diabetes, heart failure and acute myocardial infarction: a review of the literature. Open Heart 2015;2:1–12. https://doi.org/10.1136/openhrt-2014-000230. DOI: https://doi.org/10.1136/openhrt-2014-000230
Guerrero-García C, Rubio-Guerra AF. Combination therapy in the treatment of hypertension. Drugs Context 2018;7:1–9. https://doi.org/10.7573/dic.212531. DOI: https://doi.org/10.7573/dic.212531
Dharma MES, Yudista L, Suhatri S. Evaluasi Penggunaan Obat Antihipertensi di Bangsal Rawat Inap Interne RSUD Pariaman Tahun 2022. Indonesian Journal of Health Science 2024;4:608–20. https://doi.org/10.54957/ijhs.v4i5.1070. DOI: https://doi.org/10.54957/ijhs.v4i5.1070
Chen RJ, Suchard MA, Krumholz HM, Schuemie MJ, Shea S, Duke J, et al. Comparative First-Line Effectiveness and Safety of ACE (Angiotensin-Converting Enzyme) Inhibitors and Angiotensin Receptor Blockers: A Multinational Cohort Study. Hypertension 2021;78:591–603. https://doi.org/10.1161/HYPERTENSIONAHA.120.16667. DOI: https://doi.org/10.1161/HYPERTENSIONAHA.120.16667
Purwaningtyas A V, Barliana MI. Review: Efek Angiotensin Converting Enzyme Inhibitor (Acei) Dan Angiotensin Receptor Blocker (Arb) Sebagai Kardioprotektor Terhadap Cardiovascular Events. Farmaka 2021;19:76–87. https://doi.org/https://doi.org/10.24198/farmaka.v19i4.34939.g16846.
Hankey GJ. Angiotensin-converting enzyme inhibitors for stroke prevention. Stroke 2003;34:354–6. https://doi.org/10.1161/01.STR.0000054261.97525.4B. DOI: https://doi.org/10.1161/01.STR.0000054261.97525.4B
Kennelly P, Sapkota R, Azhar M, Cheema FH, Conway C, Hameed A. Diuretic Therapy in Congestive Heart Failure. Acta Cardiol 2022;77:97–104. https://doi.org/https://doi.org/10.1080/00015385.2021.1878423. DOI: https://doi.org/10.1080/00015385.2021.1878423
Lestari EFA, Susilowati S, Hermawatiningsih OD. Evaluasi Efektivitas Antihipertensi Pada Pasien Hipertensi Dengan Gagal Ginjal Kronis Di Rawat Inap Rsud Kota Madiun. Duta Pharma Journal 2021;1:25–31. https://doi.org/https://doi.org/10.47701/djp.v1i2.1217. DOI: https://doi.org/10.47701/djp.v1i2.1217
Nopitasari BL, Nurbaety B, Zuhroh H. Evaluasi Penggunaan Obat Antihipertensi pada Pasien Gagal Jantung Rawat Jalan di Rumah Sakit Umum Daerah Provinsi Nusa Tenggara Barat. Lumbung Farmasi: Jurnal Ilmu Kefarmasian 2020;1:66–72. https://doi.org/https://doi.org/10.31764/lf.v1i2.2542. DOI: https://doi.org/10.31764/lf.v1i2.2542
Adistia EA, Dini IRE, Annisaa’ E. Hubungan Antara Rasionalitas Penggunaan Antihipertensi terhadap Keberhasilan Terapi Pasien Hipertensi di RSND Semarang. Journal of Research in Pharmacy 2022;2:24–36. https://doi.org/https://doi.org/10.14710/genres.v2i1.13067. DOI: https://doi.org/10.14710/genres.v2i1.13067
Sica DA. Combination calcium channel blocker therapy in the treatment of hypertension. The Journal of Clinical Hypertension 2001;3:322–7. https://doi.org/10.1111/j.1524-6175.2001.00484.x. DOI: https://doi.org/10.1111/j.1524-6175.2001.00484.x
Kidney Disease: Improving Global Outcomes (KDIGO) Work Group. KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Journal Of The Internationa; Society Of Nephrology 2024;104:S117–2314. https://doi.org/10.1097/01.tp.0000660588.12397.e1. DOI: https://doi.org/10.1097/01.tp.0000660588.12397.e1
Rochmah, Nuur Nikmah. Swandari, Kumala Mika. Yogawati, Dwi Nursanti. Kurniawati, Marina. Danan, Dinar. Susilowati ED. Tingkat Rasionalitas Penggunaan Obat Antihipertensi Pasien Rawat Jalan di UPTD Puskesmas Kuwarasan Tahun 2020. Sains Indonesiana: Jurnal Ilmiah Nusantara 2023;1:342–50.
Wycidalesma, Yuswantina R. Evaluasi Ketepatan Dosis dan Obat Antihipertensi Terhadap Pada Pasien Hipertensi Rawat Jalan Di Rumah Sakit Bhakti Wira Tamtama Semarang. Indonesia Journal Of Pharmacy and Natural Product 2021;04:134–41. https://doi.org/https://doi.org/10.35473/ijpnp.v4i2.1328. DOI: https://doi.org/10.35473/ijpnp.v4i2.1328
Perhimpunan Dokter Hipertensi Indonesia (PERHI). Konsensus Penatalaksanaan Hipertensi 2021: Update Konsensus PERHI 2019. Jakarta: 2021.
James PA, Oparil S, Carter BL, Cushman WC, Dennison-Himmelfarb C, Handler J, et al. 2014 Evidence-based guideline for the management of high blood pressure in adults: Report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA 2014;311:507–20. https://doi.org/10.1001/jama.2013.284427. DOI: https://doi.org/10.1001/jama.2013.284427
Rashid P, Leonardi-Bee J, Bath P. Blood Pressure Reduction and Secondary Prevention of Stroke and Other Vascular Events: A Systematic Review. Stroke 2003;34:2741–9. https://doi.org/10.1161/01.STR.0000092488.40085.15. DOI: https://doi.org/10.1161/01.STR.0000092488.40085.15